HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Extensive short-bowel syndrome in neonates: outcome in the 1980s.

Abstract
Fourteen infants with extensive short-bowel syndrome (SBS) were treated from 1978 through 1987 at the Children's Hospital, Columbus, Ohio. Extensive SBS was defined as a residual jejunoileum that was 25% or less than the normal expected length for each infant's gestational age. The cause of the SBS included gastroschisis (5), jejunal atresia (5), necrotizing enterocolitis (2), midgut volvulus (1), and congenital SBS (1). Infants had a mean residual jejunoileal length of 32 cm, which represented an average of 16% of normal expected jejunoileal length for gestational age. The most significant complications were associated with total parenteral nutrition (TPN): catheter sepsis (13/14 infants); cholestasis (8/14); central venous thrombosis (4/14); and cholelithiasis (3/14). The survival rate was 86%; two infants died of end-stage liver disease. Eight of 12 survivors (67%) have had intestinal adaptation develop and have discontinued TPN; three are maintained with combined TPN-enteral feeding; and one receives only TPN. Mean cost of the initial hospitalization was $315,000 with an average stay of 450 days. Survival and eventual enteral alimentation may be expected for most neonates with extensive SBS despite significant morbidity.
AuthorsD A Caniano, J Starr, M E Ginn-Pease
JournalSurgery (Surgery) Vol. 105 Issue 2 Pt 1 Pg. 119-24 (Feb 1989) ISSN: 0039-6060 [Print] United States
PMID2492680 (Publication Type: Journal Article)
Topics
  • Adaptation, Physiological
  • Humans
  • Infant, Newborn
  • Intestines (physiopathology, surgery)
  • Malabsorption Syndromes (therapy)
  • Parenteral Nutrition, Total (adverse effects)
  • Postoperative Complications
  • Short Bowel Syndrome (mortality, physiopathology, surgery, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: